The serotonin pathway in pulmonary hypertension

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 6, 2006, Pages 621-625

  Eddahibi, S ^b   Adnot, S ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NONE

Author keywords

Pulmonary hypertension; Serotonin; Smooth muscle

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

ARTERY MUSCLE; ARTICLE; CELL HYPERPLASIA; CHRONIC LUNG DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; GENE DISRUPTION; HUMAN; HYPOXIA; IDIOPATHIC DISEASE; LUNG ARTERY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; SEROTONIN BLOOD LEVEL; SMOOTH MUSCLE FIBER; ANIMAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETIC POLYMORPHISM; GENETICS; METABOLISM; REVIEW; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; MUSCLE, SMOOTH, VASCULAR; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33749043981     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;335:609-16.
2. MacLean M, Herve P, Eddahibi S, Adnot S. 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000;131:161-8.
3. Herve P, Launay JM, Scrobohaci ML, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249-54.
4. Lee SL, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture. Circ Res 1991;68:1362-8.
5. Eddahibi S, Fabre V, Boni C, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-30.
6. Eddahibi S, Adnot S. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Respir Res 2002;3:9-13.
7. Rothman RB, Ayestas MA, Dersch CM, Baumann MH. Amino-rex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 1999;100:869-75.
8. Fanburg B, Lee SL. A new role for an old molecule: serotonin as a mitogen. Am J Physiol 1997;272:L795-L806.
9. Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-50.
10. Eddahibi S, Hanoun N, Lanfumey L, et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000;105:1555-62.
11. Guignabert C, Raffestin B, Benferhat R, et al. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 2005;111:2812-9.
12. MacLean MR, Deuchar GA, Hicks MN, et al. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 2004;109:2150-5.
13. Guignabert C, Li Z, Hanoune N, et al. Mice overexpressing the 5-hydroxytryptamine transporter in smooth muscle cells spontaneously develop pulmonary hypertension. Am J Respir Crit Care Med 2005;2:A526, abstract.
14. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Rieder P. Isolation of a cDNA encoding the humain brain serotonin transporter. J. Neural Transm (GenSect) 1993;91:67-72.
15. Willers E, Newman J, Loyd J, et al. Serotonin Transporter Polymorphisms in Familial and Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2005;ahead of print.
16. Machado R, Koehler R, Glissmeyer R, et al. Genetic association of the serotonin transporter in pulmonary arterial hypertension. Am J Respir Crit Care Med 2006; ahead of print.
17. Marcos E, Fadel E, Sanchez O, et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004;94:1203-70.
18. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130:993-8.
19. Eddahibi S, Chaouat A, Morrell N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108:1839-44.